These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3121228

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension.
    Gupta F, Karabin B, Mehdirad A.
    Clin Auton Res; 2017 Jul; 27(Suppl 1):15-16. PubMed ID: 28699047
    [No Abstract] [Full Text] [Related]

  • 23. Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus.
    Vernino S, Claassen D.
    Clin Auton Res; 2017 Jul; 27(Suppl 1):33-34. PubMed ID: 28674868
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Meningitic complications of Kawasaki disease. Clinical contribution].
    Perulli L, Da Villa M, Russo Perez G.
    Riv Neurobiol; 1981 Jul; 27(34):633-9. PubMed ID: 7052672
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. DBH deficiency in an elderly patient: efficacy and safety of chronic droxidopa.
    Despas F, Pathak A, Berry M, Cagnac R, Massabuau P, Liozon E, Galinier M, Senard JM.
    Clin Auton Res; 2010 Jun; 20(3):205-7. PubMed ID: 20063034
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Acute autonomic and sensory neuropathy: a case report.
    Kanda F, Uchida T, Jinnai K, Tada K, Shiozawa S, Fujita T, Ohnishi A.
    J Neurol; 1990 Feb; 237(1):42-4. PubMed ID: 2156957
    [Abstract] [Full Text] [Related]

  • 31. Cardiovascular Safety of Droxidopa in Patients With Symptomatic Neurogenic Orthostatic Hypotension.
    White WB, Hauser RA, Rowse GJ, Ziemann A, Hewitt LA.
    Am J Cardiol; 2017 Apr 01; 119(7):1111-1115. PubMed ID: 28159196
    [Abstract] [Full Text] [Related]

  • 32. Neurogenic orthostatic hypotension with critical illness neuropathy treated with droxidopa.
    Allen BB, Charles JA, Papadopoulos E, Avila EK.
    Auton Neurosci; 2016 Jul 01; 198():8-9. PubMed ID: 27423298
    [No Abstract] [Full Text] [Related]

  • 33. Neurogenic orthostatic hypotension: new prospects in treatment. Introduction.
    Kaufmann H.
    Clin Auton Res; 2008 Mar 01; 18 Suppl 1():1. PubMed ID: 18368299
    [No Abstract] [Full Text] [Related]

  • 34. The treatment of orthostatic hypotension with dihydroxyphenylserine.
    Freeman R, Landsberg L.
    Clin Neuropharmacol; 1991 Aug 01; 14(4):296-304. PubMed ID: 1913697
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Treatment of neurogenic postural hypotension. The search continues.
    Joshi VR, Sainani GS.
    J Assoc Physicians India; 1986 Apr 01; 34(4):245-6. PubMed ID: 3759818
    [No Abstract] [Full Text] [Related]

  • 38. The cause of eyelid ptosis, orthostatic hypotension and exercise intolerance.
    Monnens L.
    Acta Paediatr; 2022 Jun 01; 111(6):1134-1136. PubMed ID: 35202494
    [Abstract] [Full Text] [Related]

  • 39. Droxidopa (Northera) for neurogenic orthostatic hypotension.
    Med Lett Drugs Ther; 2015 Jun 22; 57(1471):92-3. PubMed ID: 26079764
    [No Abstract] [Full Text] [Related]

  • 40. Comment on gastrointestinal symptoms associated with orthostatic intolerance.
    Shin JI, Lee JS.
    J Pediatr Gastroenterol Nutr; 2006 May 22; 42(5):588. PubMed ID: 16707987
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.